Khaleghzadeh-Ahangar Hossein, Talebi Anis, Mohseni-Moghaddam Parvaneh
Department of Physiology, School of Medicine, Babol University of Medical Sciences, Babol, Iran.
Immunoregulation Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Neuroendocrinology. 2022;112(9):835-844. doi: 10.1159/000521650. Epub 2021 Dec 28.
Dementia is a neurological disorder that is spreading with increasing human lifespan. In this neurological disorder, memory and cognition are declined and eventually impaired. Various factors can be considered as the background of this disorder, one of which is endocrine disorders. Thyroid hormones are involved in various physiological processes in the body; one of the most important of them is neuromodulation. Thyroid disorders, including hyperthyroidism or hypothyroidism, can affect the nervous system and play a role in the development of dementia. Despite decades of investigation, the nature of the association between thyroid disorders and cognition remains a mystery. Given the enhancing global burden of dementia, the principal purpose of this study was to elucidate the association between thyroid disturbances as a potentially modifiable risk factor of cognitive dysfunction. In this review study, we have tried to collect almost all of the reported mechanisms demonstrating the role of hypothyroidism and hyperthyroidism in the pathogenesis of dementia.
痴呆症是一种随着人类寿命延长而日益蔓延的神经障碍。在这种神经障碍中,记忆力和认知能力会下降并最终受损。多种因素可被视为这种障碍的背景,其中之一是内分泌紊乱。甲状腺激素参与身体的各种生理过程;其中最重要的一个过程是神经调节。甲状腺疾病,包括甲状腺功能亢进或减退,可影响神经系统并在痴呆症的发展中起作用。尽管经过了数十年的研究,甲状腺疾病与认知之间关联的本质仍是个谜。鉴于痴呆症在全球范围内的负担不断加重,本研究的主要目的是阐明甲状腺紊乱作为认知功能障碍潜在可改变风险因素之间的关联。在这项综述研究中,我们试图收集几乎所有已报道的机制,以证明甲状腺功能减退和亢进在痴呆症发病机制中的作用。